Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction

American Journal of Cardiology

Volumn 93, Issue 5, 2004, Pages 532-536

  Kirtane, Ajay J ^b   Bui, Anh ^b   Murphy, Sabina A ^b   Barron, Hal V ^b   Gibson, C Michael ^a  

^a TIMI Data Coordinating Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CD 18 ANTIBODY; FIBRINOLYTIC AGENT; HEPARIN; MONOCLONAL ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGE; ANGIOGRAPHY; ARTERY; ARTICLE; BLOOD CLOT LYSIS; BLOOD PRESSURE; CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; EPICARDIUM; FEMALE; FIBRINOLYSIS; HEART INFARCTION; HEART PERFUSION; HOSPITAL ADMISSION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MODEL; NEUTROPHIL; NEUTROPHILIA; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; SYMPTOMATOLOGY; TIME; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHILS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 1442299800     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.11.013     Document Type: Article

References (35)

1. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135-1143.
2. Morrow D.A., Rifai N., Antman E.M., Weiner D.L., McCabe C.H., Cannon C.P., Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 31:1998;1460-1465.
3. Biasucci L.M., D'Onofrio G., Liuzzo G., Zini G., Monaco C., Caligiuri G., Tommasi M., Rebuzzi A.G., Maseri A. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol. 27:1996;611-616.
4. Friedman G.D., Klatsky A.L., Siegelaub A.B. The leukocyte count as a predictor of myocardial infarction. N Engl J Med. 290:1974;1275-1278.
5. Ernst E., Hammerschmidt D.E., Bagge U., Matrai A., Dormandy J.A. Leukocytes and the risk of ischemic diseases. JAMA. 257:1987;2318-2324.
6. Lowe G.D., Machado S.G., Krol W.F., Barton B.A., Forbes C.D. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost. 54:1985;700-703.
7. Barron H.V., Cannon C.P., Murphy S.A., Braunwald E., Gibson C.M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction a Thrombolysis In Myocardial Infarction 10 substudy. Circulation. 102:2000;2329-2334.
8. Barron H.V., Harr S.D., Radford M.J., Wang Y., Krumholz H.M. The association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age findings from the Cooperative Cardiovascular Project. J Am Coll Cardiol. 38:2001;1654-1661.
9. Cannon C.P., McCabe C.H., Wilcox R.G., Bentley J.H., Braunwald E., OPUS-TIMI 16 Investigators. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol. 87:2001;636-639.
10. Ensrud K., Grimm R.H. Jr. The white blood cell count and risk for coronary heart disease. Am Heart J. 124:1992;207-213.
11. Bazzoni G., Dejana E., Del Maschio A. Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica. 76:1991;491-499.
12. Kloner R.A., Giacomelli F., Alker K.J., Hale S.L., Matthews R., Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation. 84:1991;1758-1772.
13. Kawaguchi H., Mori T., Kawano T., Kono S., Sasaki J., Arakawa K. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J. 132:1996;9-12.
14. Kyne L., Hausdorff J.M., Knight E., Dukas L., Azhar G., Wei J.Y. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J. 139:2000;94-100.
15. Wong C.K., French J.K., Gao W., White H.D. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase. Am Heart J. 145:2003;95-102.
16. Baran K.W., Nguyen M., McKendall G.R., Lambrew C.T., Dykstra G., Palmeri S.T., Gibbons R.J., Borzak S., Sobel B.E., Gourlay S.G., et al. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation. 104:2001;2778-2783.
17. TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 312:1985;932-936.
18. Gibson C.M., Sandor T., Stone P.H., Pasternak R.C., Rosner B., Sacks F.M. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol. 69:1992;1286-1290.
19. Gibson C.M., Cannon C.P., Daley W.L., Dodge J.T. Jr, Alexander B. Jr, Marble S.J., McCabe C.H., Raymond L., Fortin T., Poole W.K., Braunwald E. TIMI frame count a quantitative method of assessing coronary artery flow. Circulation. 93:1996;879-888.
20. French J.K., Ellis C.J., Webber B.J., Williams B.F., Amos D.J., Ramanathan K., Whitlock R.M., White H.D. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis In Myocardial Infarction (TIMI) frame count and stenosis severity. Am J Cardiol. 81:1998;665-671.
21. Al-Mousa E.N., Dodge J.T. Jr, Rizzo M., McLean C., Ryan K., Moynihan J., Kelley M., Marble S.J., Goel M., Daley W.L., Gibson C.M. Thrombolysis In Myocardial Infarction frame count in saphenous vein grafts. Am Heart J. 135:1998;323-328.
22. Gibson C.M., Murphy S.A., Rizzo M.J., Ryan K.A., Marble S.J., McCabe C.H., Cannon C.P., Van de Werf F., Braunwald E. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation. 99:1999;1945-1950.
23. Gibson C.M., Cannon C.P., Murphy S.A., Ryan K.A., Mesley R., Marble S.J., McCabe C.H., Van De Werf F., Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 101:2000;125-130.
24. Stata Statistical Software. College Station, TX: Stata Corporation, 2000
25. Tamura A., Watanabe T., Nasu M. Association between neutrophil counts on admission and left ventricular function in patients successfully treated with primary coronary angioplasty for first anterior wall acute myocardial infarction. Am J Cardiol. 88:2001;678-680.
26. Naruko T., Ueda M., Haze K., van der Wal A.C., van der Loos C.M., Itoh A., Komatsu R., Ikura Y., Ogami M., Shimada Y., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 106:2002;2894-2900.
27. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med. 347:2002;5-12.
28. de Gaetano G., Cerletti C., Evangelista V. Recent advances in platelet-polymorphonuclear leukocyte interaction. Haemostasis. 29:1999;41-49.
29. Frangogiannis N.G., Youker K.A., Rossen R.D., Gwechenberger M., Lindsey M.H., Mendoza L.H., Michael L.H., Ballantyne C.M., Smith C.W., Entman M.L. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol. 30:1998;2567-2576.
30. Sheridan F.M., Cole P.G., Ramage D. Leukocyte adhesion to the coronary microvasculature during ischemia and reperfusion in an in vivo canine model. Circulation. 93:1996;1784-1787.
31. Lee Y.M., Hsiao G., Chen H.R., Chen Y.C., Sheu J.R., Yen M.H. Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats. Eur J Pharmacol. 422:2001;159-167.
32. Kohtani T., Abe Y., Sato M., Miyauchi K., Kawachi K. Protective effects of anti-neutrophil antibody against myocardial ischemia/reperfusion injury in rats. Eur Surg Res. 34:2002;313-320.
33. Tsao P.S., Ma X.L., Lefer A.M. Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J. 123:1992;1464-1471.
34. Nichols W.W., Mehta J.L., Donnelly W.H., Lawson D., Thompson L., ter Riet M. Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog role of endothelium-derived relaxing factor, myocardial neutrophil infiltration and prostaglandins. J Mol Cell Cardiol. 20:1988;943-954.
35. Ma X.L., Weyrich A.S., Lefer D.J., Buerke M., Albertine K.H., Kishimoto T.K., Lefer A.M. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation. 88:1993;649-658.